Drug Companies Boosted Lobbying by 23 Percent Ahead of TrumpRX Launch

Source: Truthout · Bias: Far Left

Summary

The big pharma companies involved in Trump's new drug pricing program spent over $130 million on lobbying in 2025.

Related Coverage

Daily Analysis

Read the full Parallax Pulse for May 7, 2026 — an AI-powered analysis of how Left and Right media covered the biggest stories this day.

More Headlines From May 7, 2026

Drug Companies Boosted Lobbying by 23 Percent Ahead of TrumpRX Launch
Truthout

Drug Companies Boosted Lobbying by 23 Percent Ahead of TrumpRX Launch

Far Left

The big pharma companies involved in Trump's new drug pricing program spent over $130 million on lobbying in 2025.